This idea was based on the experience from ovarian clear cell carcinoma and the presence of high hepatocyte nuclear factor-1 beta (HNF1B) levels published by Tsuchiya and colleagues [22], as well as the presence of upregulation in other cancers. This evidence concerns the gene HNF1B and ovarian clear cell cancer.